pyrroles has been researched along with Adult-Onset Still Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, X; Chi, H; Hu, Q; Jia, J; Liu, HL; Liu, T; Shi, H; Su, Y; Sun, Y; Teng, J; Wan, L; Wang, F; Wang, M; Wang, Z; Yang, C; Ye, J; Zhou, Z | 1 |
| Honda, M; Kondo, M; Kumakura, S; Moriyama, M; Murakawa, Y | 1 |
| Feist, E; Hoff, P; Ohrndorf, S; Walther, M; Weinerth, J; Wesselmann, H | 1 |
3 other study(ies) available for pyrroles and Adult-Onset Still Disease
| Article | Year |
|---|---|
Tofacitinib in refractory adult-onset Still's disease: 14 cases from a single centre in China.
Topics: Adolescent; Adult; Aged; Female; Humans; Janus Kinase Inhibitors; Male; Middle Aged; Piperidines; Pyrimidines; Pyrroles; Retreatment; Still's Disease, Adult-Onset | 2020 |
Tofacitinib-induced remission in refractory adult-onset Still's disease complicated by macrophage activation syndrome.
Topics: Aged; Fatal Outcome; Female; Humans; Janus Kinases; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Remission Induction; Still's Disease, Adult-Onset | 2020 |
[Successful treatment of adult Still's disease with tofacitinib in a HIV-2 positive female patient].
Topics: Adult; Female; HIV Infections; HIV-2; Humans; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Still's Disease, Adult-Onset; Treatment Outcome | 2020 |